TREA

88795697 - ANDELYN BIOSCIENCES RELIABLY EXPERT. PURPOSEFULLY DRIVEN.

Follow

Information

  • Trademark
  • 88795697
  • Serial Number
    88795697
  • Registration Number
    6680137
  • Filing Date
    February 13, 2020
    5 years ago
  • Registration Date
    March 22, 2022
    2 years ago
  • Transaction Date
    August 14, 2023
    a year ago
  • Status Date
    March 22, 2022
    2 years ago
  • Published for Opposition Date
    November 03, 2020
    4 years ago
  • Location Date
    February 12, 2022
    3 years ago
  • First Use Anywhere Date
    August 12, 2020
    4 years ago
  • First Use In Commerce Date
    October 25, 2021
    3 years ago
Information
Mark Drawing Code
3000
Mark Identification
ANDELYN BIOSCIENCES RELIABLY EXPERT. PURPOSEFULLY DRIVEN.
Case File Statements
  • GS0401: Manufacturing services for others in the field of pharmaceuticals, biopharmaceuticals, health care products and medical products; treatment of materials, namely, pharmaceutical and chemical products and their components used in the manufacture of pharmaceuticals and biopharmaceuticals; manufacture of pharmaceuticals and biopharmaceuticals to order and/or specification of others; contract manufacturing of pharmaceuticals, cells and gene therapy reagents
  • DM0000: The mark consists of the word "ANDELYN" in stylized font, with a honeycomb pattern beneath the right side of the word. The words "BIOSCIENCES RELIABLY EXPERT. PURPOSEFULLY DRIVEN". appear beneath the left side of "ANDELYN".
  • GS0051: Pharmaceutical preparations, biological preparations, and gene therapy products for medical or pharmaceutical purposes, namely, gene therapies, viral vectors, DNA plasmids, and nucleic-acid delivery products for use in the treatment of genetic diseases and disorders
  • CC0000: Color is not claimed as a feature of the mark.
  • D10000: "BIOSCIENCES"
  • GS0421: Product development for others relating to pharmaceuticals, biopharmaceuticals, health care products and medical products; scientific and technological consulting services in the pharmaceutical industry, and research and design relating thereto; industrial analysis in the nature of product testing and research and industrial research in the field of pharmaceuticals, biopharmaceuticals, health care products and medical products; pharmaceutical and biopharmaceutical drug development services; pharmaceutical and biopharmaceutical research and development; product development consultation; product research services, namely, providing analytical testing, biosafety testing, reporting and laboratory services for others; scientific and technical product development consulting and research services for the pharmaceutical industry; custom design and development of chemical reagents and biochemical assays
Case File Event Statements
  • 8/14/2023 - a year ago
    37 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 8/14/2023 - a year ago
    36 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 8/14/2023 - a year ago
    35 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 8/14/2023 - a year ago
    34 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN
  • 8/14/2023 - a year ago
    33 - TEAS CHANGE OF OWNER ADDRESS RECEIVED Type: COAR
  • 3/22/2022 - 2 years ago
    32 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 2/15/2022 - 3 years ago
    31 - NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Type: SUNA
  • 2/12/2022 - 3 years ago
    30 - ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Type: CNPR
  • 12/16/2021 - 3 years ago
    29 - STATEMENT OF USE PROCESSING COMPLETE Type: SUPC
  • 11/18/2021 - 3 years ago
    28 - USE AMENDMENT FILED Type: IUAF
  • 12/16/2021 - 3 years ago
    27 - CASE ASSIGNED TO INTENT TO USE PARALEGAL Type: AITU
  • 11/18/2021 - 3 years ago
    26 - TEAS STATEMENT OF USE RECEIVED Type: EISU
  • 6/19/2021 - 3 years ago
    25 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 6/17/2021 - 3 years ago
    24 - SOU EXTENSION 1 GRANTED Type: EX1G
  • 6/17/2021 - 3 years ago
    23 - SOU EXTENSION 1 FILED Type: EXT1
  • 6/17/2021 - 3 years ago
    22 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 4/7/2021 - 3 years ago
    21 - AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Type: ASGN
  • 12/29/2020 - 4 years ago
    20 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM
  • 11/3/2020 - 4 years ago
    19 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 11/3/2020 - 4 years ago
    18 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 10/14/2020 - 4 years ago
    17 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 9/27/2020 - 4 years ago
    16 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 9/27/2020 - 4 years ago
    15 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 9/27/2020 - 4 years ago
    14 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 9/27/2020 - 4 years ago
    13 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 9/27/2020 - 4 years ago
    12 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 9/24/2020 - 4 years ago
    11 - AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Type: ASGN
  • 9/21/2020 - 4 years ago
    10 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 9/21/2020 - 4 years ago
    9 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 9/21/2020 - 4 years ago
    8 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 3/19/2020 - 4 years ago
    7 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 3/19/2020 - 4 years ago
    6 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 3/19/2020 - 4 years ago
    5 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 3/18/2020 - 4 years ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 2/20/2020 - 5 years ago
    3 - NOTICE OF DESIGN SEARCH CODE E-MAILED Type: MDSC
  • 2/19/2020 - 5 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 2/17/2020 - 5 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP